openPR Logo
Press release

Drug Discovery Informatics Market Outlook to 2025 - Collaborative Drug Discovery, Inc., Jubilant Life Sciences Ltd., Thermo Fisher Scientific Inc., Charles River, Novo Informatics Pvt. Ltd.

11-06-2018 08:54 AM CET | Health & Medicine

Press release from: The Insight Partners

Drug Discovery Informatics Market

Drug Discovery Informatics Market

An exclusive Drug Discovery Informatics Market research report created through broad primary research (inputs from industry experts, companies, and stakeholders) and secondary research, the report aims to present the analysis of Global Drug Discovery Informatics Market by Type, By Application, By Region - North America, Europe, South America, Asia-Pacific, Middle East and Africa. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global Drug Discovery Informatics Market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Get Sample Copy of this Report at http://bit.ly/2ytbwv7

Large volume of data procured by innovative methods and the need for an efficient tool to analyze this data are anticipated to drive the market of drug discovery informatics in the coming years. In recent years, various collaborations have been seen amongst the drug discovery informatics providers, which proves to be a major opportunity in the market.

Leading Drug Discovery Informatics Market Players:
1. PerkinElmer Inc.
2. Schrödinger, LLC
3. Certara, L.P.
4. Infosys Limited
5. IBM
6. Collaborative Drug Discovery, Inc.
7. Jubilant Life Sciences Ltd.
8. Thermo Fisher Scientific Inc.
9. Charles River
10. Novo Informatics Pvt. Ltd.

Drug Discovery Informatics enables the users to address large volume of data storage & management and processing & analyzing the obtained results. These drug discovery informatics platforms utilize bioinformatics algorithms for processing life science data and uses various in silico models for analyzing the data obtained.

Worldwide Drug Discovery Informatics Market Analysis to 2025 is a specialized and in-depth study of the Drug Discovery Informatics industry with a focus on the global market trend. The report aims to provide an overview of global Drug Discovery Informatics Market with detailed market segmentation by product/application and geography. The global Drug Discovery Informatics Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the players and offers key trends and opportunities in the market.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Drug Discovery Informatics Market based on product and application. It also provides market size and forecast till 2025 for overall Drug Discovery Informatics Market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America (SAM), which is later sub-segmented by respective countries and segments. The report evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend and provides exhaustive PEST analysis for all five regions.

Also, key Drug Discovery Informatics Market players influencing the market are profiled in the study along with their SWOT analysis and market strategies. The report also focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years.

Reason to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Drug Discovery Informatics Market
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Drug Discovery Informatics Market, thereby allowing players to develop effective long term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.

If You want to Purchase the Report Directly: http://bit.ly/2yrgzfw

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Discovery Informatics Market Outlook to 2025 - Collaborative Drug Discovery, Inc., Jubilant Life Sciences Ltd., Thermo Fisher Scientific Inc., Charles River, Novo Informatics Pvt. Ltd. here

News-ID: 1354268 • Views: 184

More Releases from The Insight Partners

Oncology Biosimilars Market Key Insights, Booming Growth with Top Key Manufactur …
Worldwide Oncology Biosimilars Market Analysis to 2027 is a specialized and in-depth study of the Oncology Biosimilars industry with a focus on the global market trend. The report aims to provide an overview of global Oncology Biosimilars market with detailed market segmentation by product & services /application and geography. The global Oncology Biosimilars market is expected to witness high growth during the forecast period. The report provides key statistics on
Mooring Inspection Market Outlook to 2027 - Leading Players Acteon Group, Deep S …
Mooring anchoring systems are very significant to ensure the safe functionality of offshore loading systems. Thus, the reliability of mooring components is of extreme significance to safeguard breakage-free operations through the entire service life of the facility. Mooring inspection is performed on a routine basis in offshore operations to ensure the integrity of mooring components. The significance of detect defects in a mooring system to ensure safe offshore and onshore operations
Diagnostic Tympanometers Market Report Gives Immense Knowledge on the Competitiv …
Diagnostic tympanometers is an audiometric diagnostic device consisting of tone generator, pressure pump and microphone used to measure the movement of the tympanic membrane and access the function of the middle ear. This market research report provides a comprehensive picture on “Diagnostic Tympanometers Market”, from the global viewpoint, offering a forecast and statistic in terms of revenue during the forecast period. The report covers a descriptive analysis with detailed segmentation, complete
Multi Flue Chimney Caps Market Outlook to 2027 - Artis Metals, Chim Cap, Chimney …
Multi-flue chimney caps are useful in protecting the chimney crown. They are available in stainless steel, concrete, or copper. Multi-flue chimney caps can accommodate single or multiple flues in one chimney structure. A rise in commercial and residential projects is expected to generate substantial demand for multi-flue chimney caps in the forecast period. The multi flue chimney caps market is anticipated to grow in the forecast period owing to various advantages

All 5 Releases


More Releases for Drug

Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning